PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
12-Dec-2023 Antibe Therapeutics Announces Amendment to Warrant Terms Businesswire
12-Dec-2023 Bicara Therapeutics Announces Oversubscribed $165 Million Series C Financing Businesswire
12-Dec-2023 United States $36.8 Bn Active Pharmaceutical Ingredient Markets, Competition, Forecast and Opportunities, 2018-2022 and 2023-2028 - ResearchAndMarkets.com Businesswire
12-Dec-2023 United States $160+ Bn Generic Drugs Markets, Competition, Forecasts and Opportunities, 2018-2022 and 2023-2028 - ResearchAndMarkets.com Businesswire
12-Dec-2023 Introducing Portal Biotechnologies Businesswire
12-Dec-2023 United Therapeutics and Miromatrix Medical Announce Successful Tender Offer Businesswire
12-Dec-2023 CHARM Therapeutics Bolsters Leadership Team with Key Promotion and Strategic Appointment Businesswire
12-Dec-2023 OQ Chemicals Appoints Silvia Weppler as Chief Financial Officer Businesswire
12-Dec-2023 Samabriva is Set to Become a World Leader in Precision Biomanufacturing of Complex Molecules With the Announcement of a €4 Million Fundraising Round Businesswire
12-Dec-2023 SolasCure Demonstrates Proof-of-Concept in Phase lla Safety Trial of Aurase Wound Gel Businesswire
12-Dec-2023 Depixus Announces Strategic Collaboration With Daiichi Sankyo to Use MAGNA™ Technology to Accelerate RNA-targeted Drug Discovery Businesswire
12-Dec-2023 Almirall and etherna Enter Into a Multi-Target Alliance to Develop mRNA-based Therapies in Medical Dermatology Businesswire
12-Dec-2023 Sensorion Appoints CMC Expert Bernd Schmidt as New Chief Technical Officer Businesswire
12-Dec-2023 Alomone Labs Collaborates With Bioz to Strengthen Research Capabilities Through the Innovative Integration of Scientific Citations Newswire
12-Dec-2023 Meilleur Technologies Inc. Announces Use of the Next-Generation Amyloid PET Imaging Biomarker, NAV-4694, in the Young Blood Institute’s AmβARI study on Amyloid Removal Businesswire
12-Dec-2023 L&T Technology Services and bp Sign Multi-Year Engineering Services Partnership Businesswire
12-Dec-2023 Two Early Studies Evaluating Potential First-in-Class CELMoD™ Agent Golcadomide for the Treatment of Non-Hodgkin Lymphomas Presented at ASH 2023 Businesswire
12-Dec-2023 Cimeio Therapeutics Presents Data for its CD45 Universal Heme ADC at ASH Businesswire
12-Dec-2023 Bristol Myers Squibb Announces Data at ASH 2023 from Diverse Multiple Myeloma Pipeline, Underscoring Range of Tailored Treatment Approaches to Address Unique Patient Needs Businesswire
12-Dec-2023 Patient-Reported Outcomes from the CARTITUDE-4 Study Showed Clinically Meaningful Improvements in Health-Related Quality of Life and Reductions in Multiple Myeloma Symptoms Following Treatment with CARVYKTI® (ciltacabtagene autoleucel) Businesswire